PNPLA6 p.Pro512=
c.1536C>T · rs140389368 · VCV698555
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 0.066 | GERP 0.26, phastCons 0.004 |
| Overall | ||
| CADD | 12.4 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0774% | 1,292 |
| Remaining individualsnot grpmax-eligible | 0.008% | 12,497 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PNPLA6
- Protein
- p.Pro512=
- Coding
- c.1536C>T
- MANE Select
- NM_001166114
- dbSNP
- rs140389368
- Type
- single nucleotide variant
- Location
- chr19:7543012 (GRCh38)
- Gene constraint
- LOEUF 0.872 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 69.75
- Residue 512
- the 'cnmp-binding domain 2' region
Disease context
hereditary spastic paraplegia 39 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal recessive spastic paraplegia type 39 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
Similar variants
- PNPLA6 c.2936+2T>C Likely pathogenic ★★ same condition
- PNPLA6 c.315+1G>T Likely pathogenic ★★ same condition
- PNPLA6 c.316-2A>T Pathogenic ★★ same condition
- PNPLA6 c.3816+1G>A Likely pathogenic ★★ same condition
- PNPLA6 p.Ala1102Thr Pathogenic/Likely pathogenic ★★ same condition
- PNPLA6 p.Arg1089Gln Pathogenic ★★ same condition
- PNPLA6 p.Arg1089Ter Pathogenic/Likely pathogenic ★★ same condition
- PNPLA6 p.Arg1137Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pnpla6-p-pro512 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown